Literature DB >> 15887103

Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas.

Martin Anlauf1, Aurel Perren, Cora Lu Meyer, Sonja Schmid, Parvin Saremaslani, Marie L Kruse, Eberhard Weihe, Paul Komminoth, Philipp U Heitz, Günter Klöppel.   

Abstract

BACKGROUND & AIMS: The identification of precursor lesions has a great impact on the understanding of tumorigenesis. Precursor lesions of endocrine tumors are known to occur in the setting of the MEN1 syndrome. The aim of this study was to test the hypothesis that MEN1-associated duodenal gastrinomas originate from diffuse preneoplastic gastrin cell changes. Precursor lesions may precede the development of duodenal gastrinomas because, in contrast to sporadic gastrinomas, these tumors are usually multiple.
METHODS: The distribution of endocrine cells in the nontumorous duodenal tissue was analyzed qualitatively and quantitatively for 25 patients operated on for a duodenal gastrinoma. MEN1 status was assessed clinically and by polymerase chain reaction-based mutational analysis.
RESULTS: Fourteen of 25 patients with gastrinoma had proliferative, hyperplastic lesions consisting of gastrin cells in the nontumorous duodenal mucosa, similar to the gastric enterochromaffin-like cell lesions observed in chronic atrophic gastritis. All patients with Zollinger-Ellison syndrome with proven MEN1 had such proliferative gastrin cell lesions, and all patients with Zollinger-Ellison syndrome without precursor lesions were MEN1 negative.
CONCLUSIONS: Duodenal gastrinomas in MEN1, but not sporadic duodenal gastrinomas, are associated with proliferative gastrin cell changes within the nontumorous mucosa. It is likely that these lesions precede the development of MEN1-associated duodenal gastrinomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887103     DOI: 10.1053/j.gastro.2005.01.058

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1.

Authors:  D M Pritchard
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

Review 2.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 3.  [Prophylactic pancreas surgery].

Authors:  P Langer; M Rothmund; D K Bartsch
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 4.  [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 5.  Epigenetic regulation by the menin pathway.

Authors:  Zijie Feng; Jian Ma; Xianxin Hua
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

6.  Regulated expression of the human gastrin gene in mice.

Authors:  Edith Mensah-Osman; Ed Labut; Yana Zavros; Mohamad El-Zaatari; David J Law; Juanita L Merchant
Journal:  Regul Pept       Date:  2008-03-28

7.  Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and how.

Authors:  Alberto Falchetti
Journal:  F1000 Med Rep       Date:  2010-02-24

8.  Modulation by miR-29b of intestinal epithelium homoeostasis through the repression of menin translation.

Authors:  Miao Ouyang; Weijie Su; Lan Xiao; Jaladanki N Rao; Liping Jiang; Yanwu Li; Douglas J Turner; Myriam Gorospe; Jian-Ying Wang
Journal:  Biochem J       Date:  2015-01-15       Impact factor: 3.857

9.  A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.

Authors:  Marc J Berna; Bruno Annibale; Massimo Marignani; Tu Vinh Luong; Vito Corleto; Andrea Pace; Tetsuhide Ito; David Liewehr; David J Venzon; Gianfranco Delle Fave; Cesare Bordi; Robert T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

Review 10.  Multiplicity of hormone-secreting tumors: common themes about cause, expression, and management.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2013-06-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.